1 Vassart G, Dumont JE, Refetoff S. Thyroid disorders. The metabolic and molecular bases of inherited disease. Scriver C.R. Beaudet AL, Sly WS, Valle D (Eds), McGraw-Hill, 7th edition 1995; pp. 2883-2926.

2 Martino E, Bartelena L, Pinchera A. Central hypothyroidism. In: Werner and Ingbar's The Thyroid, 8th edition. Braverman LE, Utiger RD (Eds), Lippincott,Williams and Wilkins, Philadelphia 2000; pp. 762-773.

3 Pendred V. Deaf mutism and goitre. Lancet 1896; 2: 532.

4 Osler W. Sporadic cretinism in America. Trans Congress Am Physicians Surg. 1897; 4: 169-206.

5 Lander ES et al. International human genome sequencing consortium. Initial sequencing and analysis of the human genome. Nature 2001; 409: 860-921.

6 Venter JC et al. The sequence of the human genome. Science 2001; 291: 1304-1351.

7 Moreno JC, de Vijlder JJM, Vulsma T, Ris-Stalpers C. Genetic basis of hypothyroidism: recent advances, gaps and strategies for future research. Trends Endocrinol Metab 2003;14:318-326.

8 Pop VJ, Kuijpens JL, van Baar AL, Verkerk G, van Son MM, de Vijlder JJM, Vulsma T, Wiersinga WM, Drexhage HA, Vader HL. Low maternal free thyroxine concentrations during early pregnancy associated with impaired psychomotor development in infancy. Clin Endocrinol 1999; 50: 149-155.

9 Vulsma T, Gons MH, de Vijlder JJM. Maternal-fetal transfer of thyroxine in congenital hypothyroidism due to a total organification defect or thyroid agenesis. N Engl J Med 1989; 321: 13.

10 Brown AL, Fernhoff PM, Milner J, McEwen C, Elsas LS. Racial differences in the incidence of congenital hypothyroidism. J Pediatr 1981; 99: 934-936.

11 Rosenthal M, Addison GM, Price DA. Congenital hypothyroidism: increased incidence in Asian families. Arch Dis Child 1988; 63: 790-793.

12 LaFranchi SH, Hanna CE, Krainz PL, Skeels MR, Miyanira RS, Sesser DE. Screening for congenital hypothyroidism with specimen collection at two time periods: results of the Northwest Regional Screening program. Pediatrics 1985; 76: 734-740.

13 Vulsma T, Delemarre HA, de Muinck Keizer SMPF et al. Detection and classification of congenital thyrotropin deficiency in the Netherlands. In: Drexhage HA, de Vijlder JJM, Wiersinga WM (Eds). The thyroid gland, environment and autoimmunity. Elsevier Science Publishers BV, Amsterdam 1990; 343-346.

14 De Vijlder JJM, Vulsma T. Hereditary metabolic disorders causing hypothyroidism. In: Werner and Ingbar's The Thyroid, 8th edition. Braverman LE and Utiger RD (Eds). Lippincott Williams & Wilkins, 2000; pp. 733-742.

15 De Vijlder JJM, Vulsma T. Genetic defects in thyroid hormone synthesis and action: Defects in thyroid hormone synthesis. In: Endocrinology. DeGroot L (Ed)2000; pp 1594-1602.

16 De Vijlder JJM. Primary congenital hypothyroidism: defects in iodine pathways. Europ J Endocrinol 2003;149:247-256.

17 Fugazzola L, Persani L, Mannavola D, Reschini E, Vannucchi G, Weber G, Beck-Peccoz P. Recombinant human TSH testing is a valuable tool for differential diagnosis of congenital hypothyroidism during L-thyroxine replacement. Clin Endocrinol 2003;59:230-236.

18 Bakker B, Kempers MJ, De Vijlder JJM, Van Tijn DA, Wiedijk BM, Van Bruggen M, Vulsma T. Dynamics of the plasma concentrations of TSH, FT4 and T3 following thyroxine supplementation in congenital hypothyroidism. Clin Endocrinol 2002;57:529-537.

19 Dattani MT, Robinson IC. The molecular basis for developmental disorders of the pituitary gland in man. Clin Genet 2000; 57: 337-346.

20 Schmitt S, Biason-Lauber A, Betts D, Schoenle EJ. Genomic Structure, chromosomal localization, and expression of the human LIM-homeobox3 (LHX3) gene. Biophys Res Comm. 2000;274: 49-58.

21 Netchine I, Sobrier M-L, Krude H, Schnabel K, Magnie M, Marcos E, Duriez B et al. Mutations in LHX3 result in a new syndrome revealed by combined pituitary hormone deficiency. Nature Genet. 2000;25:182-186.

22 Sloop KW, Parker GE, Hanna KR, Wright HA, Rhodes SJ. LHX3 transcription factor mutations associated with combined pituitary hormone deficiency impair the activation of pituitary target genes. Gene 2001;265: 61-69.

23 Dattani MT, Martinez-Barbera JP, Thomas PQ et al. Mutations in the homeobox gene HESX1/hesx1 associated with septo-optic dysplasia in human and mouse. Nature Genet 1998;19:125-133.

24 Thomas PQ, Dattani MT, Brickman JM, McNay D, Warne G, Zacharin M, Cameron F, Hurst J, Woods K, Dunger D, Stanhope R, Forrest S, Robinson IC, Beddington RS. Heterozygous HESX1 mutations associated with isolated congenital pituitary hypoplasia and septo-optic dysplasia. Hum Mol Genet. 2001;10:39-45.

25 Brickman JM, Clements M, Tyrell R, McNay D, Woods K, Warner J, Stewart A, Beddington RSP, Dattani M. Molecular effects of novel mutations in Hesx1/HESX1 associated with human pituitary disorders. Development 2001;128:5189-5199.

26 Tajima T, Hattorri T, Nakajima T, Okuhara K, Sato K, Abe S, Nakae J, Fujieda K. Sporadic heterozygous frameshift mutation of HESX1 causing pituitary and optic nerve hypoplasia and combined pituitary hormone deficiency in a Japanese patient. J Clin Endocrinol Metab. 2003;88:45-50.

27 Cogan JD, Wu W, Phillips JA, Arntholdt IJ, Fofanova OV, Osorio MG, Bireau I, Moreno A, Mendonca BB. The PROP1 2-base pair deletion is a common cause of combined pituitary hormone deficiency. J Clin Endocrinol 1998;83:3346-49.

28 Wu W, Cogan JD, Pfaffle RW et al. Mutations in PROP1 cause familial combined pituitary hormone deficiency. Nature Genet 1998;18:147-149.

29 Fofanova O, Takamura N, Kinoshita E et al. Compound heterozygous deletion of the PROP1 gene children with combined pituitary hormone deficiency. J Clin Endocrinol Metab 1998;83:2601-2604.

30 Takamura N, Fofanova OV, Kinoshita E, Yamashita S. Gene analysis of PROP1 in dwarfism with combined pituitary hormone deficiency. Growth Horm IGF Res 1999;9(supB):12-17.

31 Deladoey J, Fluck C, Buyukgebiz A, Kuhlmann BV, Eble A, Hindmarsh PC, Wu W, Mullis PE. "Hot spot" in the PROP1 gene responsible for combined pituitary hormone deficiency. J Clin Endocrinol Metab 1999;84:1645-1650.

32Rosenbloom AL, Selman Almonte A, Brown MR, Fisher DA, Baumbach L, Parks JS. Clinical and biochemical phenotype of familial anterior hypopituitarism from mutation of the PROP1 gene. J Clin Endocrinol Metab 1999;84:50-57.

33 Mendonca BB, Osorio MG, Latronico AC, Estefan V, Lo LS, Arnhold IJ. Longitudinal hormonal and pituitary imaging changes in two females with combined pituitary hormone deficiency due to a deletion of A301,G302 in the PROP1 gene. J Clin Endocrinol Metab 1999;84:942-945.

34 Vallette-Kasic S, Barlier A, Teinturier C, Diaz A, Manavela M, Berthezene F, Bouchard P, Chaussain JL, Brauner R, Pellegrini-Bouiller I, Jaquet P, Enjalbert A, Brue T. PROP1 screening in patients with multiple pituitary hormone deficiency reveals two sites of hypermutability and a high incidence of corticotroph deficiency. J Clin Endocrinol Metab 2001;86:4529-4535.

35 Lamesch C, Neumann S, Pfaffle R, Kiess W, Paschke R. Adrenocorticotrope deficiency with clinical evidence for late onset in combined pituitary hormone deficiency caused by a homozygous 301-302delAG mutation of the PROP1 gene. Pituitary 2002;5:163-8.

36 Duquesnoy P, Roy A, Dastot F, Ghali I, Teinturier C, Netchine I, Cacheux V, Hafez M, Salah N, Chaussain J-L, Goossens M, Bougneres P, Amselem S. Human PROP1: cloning, mapping, genomic structure; Mutations in familial combined pituitary hormone deficiency. FEBS letters 1998;437:216-220.

37 Fluck C, Deladouy J, Rutishauser K, Eble A, Marti U, Mullis PE. Phenotypic variability in familial combined pituitary hormone deficiency caused by a PROP1 gene mutation resulting in the substitution of Arg --> Cys at codon 120 (R120C). J Clin Endocrinol Metab 1998;83:3727-3734.

38 Agarwal G, Bhatia V, Cook S, Thomas PQ. Adrenocorticotropin deficiency in combined pituitary hormone deficiency patients homozygous for a novel PROP1 deletion. J Clin Endocrinol Metab 2000;85:4556-4561.

39 Osorio MGF, Kopp P, Marui S, Latronico AC, Mendonca BB, Arnhold IJP. Combined pituitary hormone deficiency caused by a novel mutation of a highly conserved residue (F88S) in the homeodomian of PROP-1. J Clin Endocrinol Metab 2000;85:2779-2785.

40 Arrayo A, Pernasetti F, Vasilyev VV, Amato P, Yen SS, Mellon PL. A unique case of combined pituitary hormone deficiency caused by a PROP1 gene mutation (R120C) associated with normal height and absent puberty. Clin Endocrinol (Oxf) 2002;57:283-291.

41 Voss J.W., Rosenfeld M.G. Anterior Pituitary Development. Short tales from dwarf mice. Cell 1992;70:527-530.

42 Collu R. Genetic aspects of central hypothyroidism. J Endocrinol Invest 2000;23:125-134.

43 Tatsumi K, Miyai K, Notomi T, Kaibe K, Amino N, Mizuno Y, Kohno H. Cretinism with combined hormone deficiency caused by a mutation in the PIT1 gene. Nat Genet 1992;1:56-58.

44 Pfaffle RW, DiMattia GE, Parks JS et al. Mutation of the POU-specific domain of Pit-1 and hypopituitarism without pituitary hypoplasia. Science 1992; 257: 1118-1121.

45 Radovick S, Nations M, Du Y, Berg LA, Weintraub BD, Wondisford FE. A mutation in the POU-homeodomain of Pit-1 responsible for combined pituitary hormone deficiency. Science 1992;292:1115-1121.

46 Ohta K, Nobukuni Y, Mitsubuchi H, Fujimoto S, Matsuo N, Inagaki H, Endo F, Matsuda I. Muttaions in the Pit-1 gene in children with combined pituitary hormone deficiency. Biochem Biophys Res Commun 1992;189:851-855.

47 Irie Y, Tatsumi K, Ogawa M, Kamijo T, Preeyasombat C, Suprasongsin C, Amino N. A novel E250X mutation of the PIT1 gene in a patient with combined pituitary hormone deficiency. Endocr J 1995;42:351-354.

48 Pellegrini-Bouiller I, Belicar P, Barlier A, Gunz G, Charvet JP, Jaquet P, Brue T, Vialettes B, Enjalbert A. A new mutation in the gene encoding the transcription factor Pit-1 is responsible for combined pituitary hormone deficiency. J Clin Endocrinol Metab 1996;81:2790-2796.

49 Fofanova OV, Takamura N, Kinoshita E et al. Rarity of PIT1 involvement in children from Russia with combined pituitary hormone deficiency. Am J Med Genet 1998; 77: 360-365.

50 Brown MR, Parks JS, Adess ME, Rich BH, Rosenthal IM, Voss TC, VanderHeyden TC, Hurley DL. Central hypothyroidism reveals compound heterozygous mutations in the Pit-1 gene. Horm Res 1998;49:98-102.

51 Hendriks-Stegeman BI, Augustijn KD, Bakker B, Holthuizen P, van der Vliet PC, Jansen M. Combined pituitary hormone deficiency cuased by compound heterozygosity for two novel mutations in the POU domain of the Pit1/POU1F1 gene. J Clin Endocrinol Metab 2001;86:1545-1550.

52 Blankenstein O, Muhlenberg R, Kim C, Wuller S, Pfaffle R, Heimann G. A new C-terminl located mutation (V272ter) in the PIT-1 gene manisfestating with severe congenital hypothyroidism. Possible functionality of the PIT-1 C-terminus. Horm Res 2001;56:81-86.

53 Gat-Yablonski G, Lazar L, Pertzelan A, Philip M. A novel muttaion in PIT-1: phenotypic variability in familial combined pituitary hormone deficiencies. J Pediatr Endocrinol Metab 2002;15:325-330.

54 McLennan K, Jeske Y, Cotterill A, Cowley D, Penfold J, Jones T, Howard N, Thomsett M, Choong C. Combined pituitary hormone deficiency in Australian children: clinical and genetic correlates. Clin Endcrinol (Oxf) 2003;56:785-794.

55 Samlemi S, Besson A, Eble A, Gallati S, Pfaffle RW, Mullis PE. New N-terminal located mutation (Q4ter) within the POU1F1-gene (PIT-1) causes recessive combined pitiutary hormone deficiency and variable phenotype. Growth Horm IGF Res 2003;13:264-268.

56 Duthie SM, Taylor PM, Anderson L, Cook L, Eidne KA. Cloning and functional characterization of the human TRH receptor. Mol Cell Endocrinol 1993; 95: R11-R15.

57 Hinuma S, Hosoya M, Ogi K, Tanaka H, Nagai Y, Onda H. Molecular cloning and functional expression of a human thyrotropin-releasing hormone (TRH) receptor gene. Biochim Biophys Acta 1994; 1219: 251-259.

58 Collu R, Tang J, Castagne J et al. A novel mechanism for isolated central hypothyroidism: inactivating mutations in the thyrotropin-releasing hormone receptor gene. J Clin Endocrinol Metab 1997; 82: 1561-1565.

59 Dracopoli NC, Retting WJ, Whitfield GK et al. Assignment of the gene for the b-subunit of thyroid stimulating hormone to the short arm of human chromosome 1. Proc Natl Acad Sci USA 1986; 83: 1822.

60 Cohen RN, Weintraub BD, Wondisford FE. Thyrotropin; chemistry and biosynthesis of thyrotropin. Werner and Ingbar's The Thyroid, 8th edition. Braverman LE and Utiger RD (eds). Lippincott William & Wilkins. A Wolters Kluwer company, Philadelphia 2000; pp. 202-219.

61 Lapthorn A.J., Harris D.C., LittleJohn A., Lustbader J.W. Canfield R.E., Machin K.J., Morgan F.J. and Isaacs N.W. Crystal structure of human chorionic gonadotropin. Nature, 1994;369:455-461.

62 Miyai K, Azukizawa M, Kumahara Y. Familial isolated thyrotropin deficiency with cretinism. New Engl J Med 1971; 285: 1043-1048.

63 Hayashizaki Y, Hiraoka Y, Tatsumi K et al. Deoxyribonucleic acid analyses of five families with familial inherited thyroid stimulating hormone deficiency. J Clin Endocrinol Metab 1990;71:792-796.

64 Dacou-Voutetakis C, Feltquate DM, Drakopoulou M et al. Familial hypothyroidism caused by a nonsense mutation in the thyroid stimulating hormone beta-subunit gene. Am J Hum Genet 1990; 46: 988.

65 Medeiros-Neto G, Herodotou DT, Rajan S et al. A circulating biologically inactive thyrotropin caused by a mutation in the beta subunit gene. J Clin Invest 1996; 97: 1250-1256.

66 Doeker BM, Pfaffle RW, Pohlenz J, Andler W. Congenital central hypothyroidism due to a homozygous mutation in the thyrotropin beta-subunit gene follows an autosomal recessive inheritance. J Clin Endocrinol Metab 1998;83:1762-1765.

67 Biebermann H, Liesenkotter KP, Emeis M, Oblanden M, Gruters A. Severe congenital hypothyroidism due to a homozygous mutation of the betaTSH gene. Pediatr res 1999;46:170-173.

68 Heinrichs C, Parma J, Scherberg NH, Delange F, van Vliet G, Duprez L, Bourdoux P, Bergmann P, Vassart G, Refetoff S. Congenital isolated hypothyroidism cuased by a homozygous mutation in the TSH-beta subunit gene. Thyroid 2000;10:387-391.

69 Bonomi M, Proverbio MC, Weber G, Chiumello G, Beck-Peccoz P, persani L. Hyperplastic pituitary gland, high serum glycoprotein hormone alpha-subunit, and variable circulating thyrotropin (TSH) levels as a hallmark of central hypothyroidism due to mutations of the TSH beta gene. J Clin Endocrinol Metab 2001;86:1600-1604.

70 Vuissoz JM, Deladouy J, Buyukgebiz A, Cemeroglu P, Gex G, Gallati S, Mullies PE. New autosomal recessive mutation of the TSH-beta subunit gene cuasing central isolated hypothyroidism. J Clin Endocrinol Metab 2001;86:4468-4471.

71 Brumm H, Pfeufer A, Biebermann H, Schnabel D, Deiss D, Gruters A. Congenital central hypothyroidism due to homozygous thyrotropin beta 313 delta T mutation is caused by a founder effect. J Clin Endocrinol Metab 2002;87:4811-4816.

72 Pohlenz J, Dumitrescu A, Aumann U, Koch G, Melchior R, prawitt D, Refetoff S. Congenital secondary hypothyroidism cuased by exon skipping due to a homozygous donor splice mutation in the TSHbeta-subunit gene. J Clin Endocrinol Metab 2002;87:336-339.

73 Sertedaki A, Papadimitriou A, Voutetakis A, Dracopoulou M, Maniati-Christidi M, Dacou-Voutetakis C. Low TSH congeital hypothyroidism: identification of a novel mutation of the TSH beta-subunit gene in one sporadic case (C85R) and of mutation Q49stop in two siblings with congenital hypothyroidism. Pediatr Res 2002;52:935-941.

74 McDemott MT, Haugen BR, Black JN, Wood WM, Gordon DF, Ridgway Ec. Congenital isolated central hypothyroidism caused by a "hot spot" mutation in the thyrotropin-beta gene. Thyroid 2002;12:1141-1146.

75 Deladouy J, Vuissoz JM, Domene HM, Malik N, Gruneiro-Papndieck L, Chiesa A, Heinrich JJ, Mullis PE. Congenital secondary hypothyroidism due to a mutation C105Vfs114X thyrotropin-beta mutation: genetic study of five unrelated families from Switzerland and Argentina. Thyroid 2003;13:553-559.

76 Macchia P. Recent advances in understanding the molecular basis of primary congenital hypothyroidism. Molec Med Today 2000; 6: 36-42.

77 Di Lauro R, De Felice M. Thyroid Gland : Anatomy and development In Endocrinology 4th edition 2001. Edited by DeGroot LJ, Jameson JL. W.B. Saunders Company, Philadelphia,pp.1268-1277.

78 Kimura S, Hara Y, Pineau T et al. the T/ebp null mouse: thyroid-specific enhancer-binding protein is essential for organogenesis of the thyroid lung ventral forebrain and pituitary. Genes Develop 1996; 10: 60-69.

79 Devriendt K, Van Hole C, Matthijs G, de Zegher F. Deletion of thyroid transcription factor-1 gene in an infant with neonatal thyroid dysfunction and respiratory failure. N Engl J Med 1998; 338: 1317-1318.

80 Krude H, Schutz B, Biebermann H, von Moers A, Schnabel A, Neitzel H, Tonnies H, Weise D, Lafferty A, Schwarz S, DeFelice M, von Deimling A, van Landeghem F, DiLauro R, Gruters A. Choreoathetosis, hypothyroidism and pulmonary alterations due to human NKX2-1 haploinsufficiency. J Clin Invest 2002;109:475-480.

81 Iwatani N, Mabe H, Devriendt K, Kodama M, Miike T. Deletion of NKX2.1 gene encoding thyroid transcription factor-1 in two siblings with hypothyroidism and respiratory failure. J Pediatr 2000; 137: 272-276.

82 Pohlenz J, Dumitrescu A, Zundel D, Martine U, Schonberger w, Koo E, Weiss RE, Cohen RN, Kimura S, Refetoff S. Partial deficiency of thyroid transcription factor 1 produces predominantly neurological defects in humans and mice. J Clin Invest 2002;109:469-473.

83 Moeller LC, Kimura S, Kusakabe T, Liao XH, Van Sande J, Refetoff S. Hypothyroidism in thyroid transcription factor 1 haploinsufficiency is caused by reduced expression of the thyroid stimulating hormone receptor. Mol Endocrinol 2003;17:2295-2302

84 De Felice M, Ovitt C, Biffali E et al. A mouse model for hereditary thyroid dysgenesis and cleft palate. Nature Genet 1998;19:395-398.

85 Clifton-Bligh RJ, Wentworth JM, Heinz P et al. Mutation of the gene encoding human TTF-2 associated with thyroid agenesis , cleft palate and choanal atresia. Nature Genet 1998; 19: 399-401.

86 Castanet M, Park S-M, Smith A, Bost M, Leger S, Lyonnet S, Pelet A, Czernichow P, Chatterjee K, Polak M. A novel loss-of-function mutation in TTF-2 is associated with congenital hypothyroidism, thyroid agenesis and cleft palate. Hum. Mol. Genet. 2002;11:2051-2059.

87 Strachan T, Read AP. PAX genes. Curr Opin Genet Dev 1994;4:427-438.

88 Macchia PE, Lapi P, Krude H et al. PAX 8 mutations associated with congenital hypothyroidism caused by thyroid dysgenesis. Nature Genet 1998;19:83-86.

89 Vilain C, Rydlewski C, Duprez L, Heinrichs C, Abramowicz M, Malvaux P, Renneboog B, Parma J, Costagliola S, Vassart G. Autosomal dominant trasnmission of congenital thyroid hypoplasia due to loss-of-function mutation of OAX8. J Clin Endocrinol Metab 2001;86:234-238.

90 Congdon T, Nguyen LQ, Nogueira CR, Habiby RL, Medeiros-Neto G, Kopp P. A novel mutation (Q40P) in PAX8 associated with congenital hypothyroidism and thyroid hypoplasia: evidence for phenotypic variability in mother and child. J Clin Endocrinol Metab 2001;86:3962-3967.

91 Komatsu M, Takahashi T, Takahashi I, Nakamura M, Takahashi I, Takada G. Thyroid dysgenesis caused by PAX8 mutation: the hypermutability with CpG dinucleotides at codon 31. J Pediatr 2001;139:597-599.

92 Damante G. Thyroid defects due to Pax8 gene mutations. Eur J Endocrinol 1998;139: 563-566.

93 Tell G, Pellizarri L, Cimarosti D, Pucillo C, Damante G. Ref-1 controls Pax-8 DNA-binding activity. Biochem Biophys Res Com 1998;252:178-183.

94 Xie J, Pannain S, Pohlenz J et al. Resistance to thyrotropin (TSH) in three families is not associated with mutations in the TSH receptor or TSH. J Clin Endocrinol Metab 1997;82:3933-3940.

95 Marians RC, Ng L, Blair HC, Unger P, Graves PN, Davies TF. Defining thyrotropin-dependent and -independent steps of thyroid hormone synthesis by using thyrotropin receptor-null mice. Proc Natl Acad Sci USA 2002;99:15776-15781.

96 Postiglione M P, Parlato R, Rodriguez-Mallon A, Rosica A, Mithbaokar P, Maresca M, Marians RC, Davies TF, Zannini MS, De Felice M, Di Lauro R. Role of the thyroid-stimulating hormone receptor signaling in development and differentiation of the thyroid gland. Proc Natl Acad Sci USA 2002;99:15462-15467.

97 Sunthornthepvarukui, T, Gottschalk ME, Hayashi Y, Refetoff S. . Resistance to thyrotropin caused by mutations in the thyrotropin receptor gene. New Engl J Med 1995;332:155-160.

98 Biebermann H, Schoneberg T, Krude H, Schultz G, Gudermann T, Gruters A. Mutations of the human thyrotropin receptor gene causing thyroid hypoplasia and persistent congenital hypothyroidism. J Clin Endocrinol Metab 1997;83:3471-3480.

99 Albright F, Burnett CH, Smith PH, Parson W. Pseudohypoparathyroidism an example of "Seabright-Bantam syndrome" Report of three cases. Endocrinology 1942;30:922-932.

100 Weinstein LS, Yu S, Warner DR, Liu J. Endocrine manifestations of stimulatory G Protein ?-subunit mutations and the role of genomic imprinting. Endocrine Reviews 2001;22:675-705.

101 Dupuy C, Virion A, Ohayon R, et al. Mechanism of hydrogen peroxide formation catalyzed by NADPH oxidase in thyroid plasma membrane. J Biol Chem 1991;266:3739-3743.

102 Dohan O, De la Vieja A, Carrasco N. Molecular study of the sodium-iodide symporter (NIS): A new field in thyroidology. Endocr rev 2003;24:48-77.

103 Royaux IE, Suzuki K, Mori A, Katoh R, Everett LA, Kohn LD, Green Ed. Pendrin, the protein encoded by the pendred syndrome gene (PDS), is a apical porter of iodie in the thyroid and is regulated by thyroglobulin in FRTL-5 cells. Endocrinol 2000;141:839-845.

104 Yoshida A, Taniguchi S, Hisatome I, Royaux IE, Green ED, Kohn LD, Suzuki K. Pendrin is an iodide specific apical porter responsible for iodide efflux from thyroid cells. J Clin Endocrinol Metab 2002;87:3356-3361.

105 Rodriquez A, Perron B, Lacroix L, Caillou B, Leblanc G, Schlumberger M, Bidart J, Pourcher T. Identification and characterization of a putative human iodide transporter located at the apical membrane of thyrocytes. J Clin Endocrinol Metab 2002;87:3500-3503.

106 Dai G, Levy O, Carrasco N. Cloning and characterisation of the thyroid iodide symporter. Nature 1996; 379: 458-460.

107 Smanik PA, Ryu KY, Theil KS, Mazzaferri EL, Jhiang SM. Expression, exon-intron organization and chromosome mapping of the human sodium iodide symporter. Endocrinology 1997;138:3555-3558.

108 De la Vieja A, Dohan O, Levy O, Carrasco N. Molecular analysis of the sodium/iodide symporter: Impact on thyroid and extrathyroid pathophysiology. Phys Rev 2000; 80: 1083-1118.

109 Vulsma T, Rammeloo JA, Gons MH, de Vijlder JJM. The role of serum thyroglobulin concentration and thyroid ultrasound imaging in the detection of iodide transport defects in infants. Acta Endocrinol 1991;124:405-410.

110 Levy O, Ginter CS, De la Vieja A, Levy D, Carrasco N. Identification of a structural requirement for thyroid Na+/l symporter (NIS) junction from analysis of a mutation that causes human congenital hypothyroidism. FEBS letters 1998;429:36-40.

111 Dohan O, Gavrielides MV, Ginter C, Amzel LM, Carrasco N. Na+/I- symporter activity requires a small and uncharged amino acid residue at position 395. Molecular Endocrinology 2002;16:1893-1902.

112 Pohlenz J, Duprez L, Weiss RE, Vassart G, Refetoff S, Costagliola S. Failure of membrane targeting causes the functional defect of two mutant sodium iodide symporters. J Clin Endocrinol Metab 2000;85:2366-2369.

113 Scott FA, Wang R, Kreman TM, Sheffiel VC, Karniski LP. The Pendred syndrome gene encodes a chloride-iodide transport protein. Nature Genet 1999;139:440-443.

114 Van Hauwe P, Everett LA, Coucke P et al. Two frequent missense mutations in Pendred syndrome. Hum Mol Genet 1998;7:1099-1104.

115 Borck G, Roth C, Martine U, Wildhardt G, Pohlenz J. Mutations in the PDS gene in german families with Pendred's syndrome: V138F is a founder mutation. J Clin Endocrinol Metab 2003;88:2916-2921.

116 Reardon W, Omahney CF, Trembath R, Jan H, Phelps PD. Enlarged vestibualr aqueduct: a radiological marker of Pendred syndrome, and mutation of the PDS gene. Q J Med 2000;93:99-104.

117 Lopez-Bigas N, Melchionada S, de Cid R,Grifa A, Zelante L, Govea N, Arbones ML, Gasparini P, Estivill X. Erratum: Identification of five new mutations of PDS/SLC26A4 in mediterranean families with hearing impairment. Hum Mutat. Mutation in brief #514 (2002) online.

118 Spitzweg C, Heufelder AE, Morris JC. Thyroid iodine transport. Thyroid 2000;10:321-330.

119 De Vijlder JJM, den Hartog MT. Anionic iodotyrosine resdues are required for iodothyronine synthesis. Eur J Endocrinol 1998;138:227-231.

120 Kimura S, Hong US, Kotani T et al. Structure of the human thyroid peroxidase gene: comparison and relationship to the human myeloperoxidase gene. Biochemistry 1989;28:4481-4489.

121 Bakker et al. Two decades of screening for congenital hypothyroidism in the Netherlands: TPO gene mutations in total iodide organification defects (an update). J Clin Endocr Metab 2000; 85 (10): 3708-3712.

122 Bakker B, Bikker H, Hennekam RC, Lommen EJ, Schipper MG, Vulsma T, de Vijlder JJM. Maternal isodisomy for chromosome 2p causing severe congenital hypothyroidism. J Clin Endocrinol Metab. 2001;86:1164-1168.

123 Fugazzola L, Cerutti N, Mannavola D, Vannucchi G, Fallini C, Persani L, Beck-Peccoz P. Monoallelic expression of mutant thyroid peroxidase allele causing total iodide organification defect. J Clin Endocrinol Metab 2003;88:3264-3271.

124 Kotani T, Umeki K, Kawano JI, Suganuma T, Hishinuma A, Ieiri T, Harada S. Partial iodide organification defect caused by a novel mutation of the thyroid peroxidase gene in three siblings. Clinical Endocrinology.2003; 59:198-206.

125 De Deken X, Wang D, Many MC, Costagliola S, Libert F, Vassart G, Dumont JE, Miot F. Cloning of two human thyroid cDNAs encoding new members of the NADPH oxidase family. J Biol Chem 2000; 275: 23227-33.

126 Moreno JC, Bikker H, Kempers MJ, Van Trotsenburg ASP, Baas F, De Vijlder JJM, Vulsma T, Ris-Stalpers C. Inactivating mutations in the gene for thyroid oxidase 2 (THOX2) and congenital hypothyroidism. N Engl J Med 2002;347:95-102.

127 Van de Graaf SAR, Pauws E, de Vijlder JJM, Ris-Stalpers C. The revised 8307 base pair coding sequence of human thyroglobulin transiently expressed in eukaryotic cells. Eur J Endocrinol 1997;136:508-515.

128 Mendive FM, Rivolta CM, Vassart G, Targovnik HM. Genomic organization of the 3'region of the human thyroglobulin gene. Thyroid 1999;9:903-912.

129 Malthiery Y, Lissitzky S. the primary structure of human thyroglobulin deduced from the sequence of its 8448 base complementary DNA. Eur J Biochem 1987; 165: 491-498.

130 Den Hartog MT, Sijmons CC, Bakker O, Ris-Stalpers C, de Vijlder JJM. The importance of the content and localization of tyrosine residues for thyroxine formation within the N-terminal part of human thyroglobulin. Eur J Endocrinol 1995; 132: 611-617.

131 De Vijlder JJM, Ris-Stalpers C, Vulsma T. On the origin of circulating thyroglobulin. Eur J Endocrinol 1999; 140: 7-8.

132 Medeiros-Neto GA, Marcondes JA, Cavaliere H, Wajchenberg BL, Knobel M. Serum thyroglobulin (Tg) stimulation with bovine TSH: a useful test for diagnosis for congenital goitrous hypothyroidism due to defective Tg synthesis. Acta Endocrinol 1985;110:61-65.

133 Enrique J, Santelices R, Hishihara M, Schneider A. Low molecular weight thyroglobulin leading to a goiter in a 12 year old girl. J Clin Endocrinol Metab 1984; 58: 256.

134 De Vijlder JJM, Veenboer GJM, van Dijk JE. Thyroid albumin originates from blood. Endocrinology 1992;131:578-584.

135 Gons MH, Kok JH, Tegelaers WHH, de Vijlder JJM. Concentration of plasma thyroglobulin and urinary excretion of iodinated material in the diagnosis of thyroid disorders in congenital hypothyroidism. Acta Endocrinol 1983; 104: 27.

136 Van de Graaf SAR, Ris-Stalpers C, Pauws E, Mendive FM, Targovnik, de Vijlder JJM. Up to date with human thyroglobulin. J Endocrinol 2001;170:307-321.

137 Ahlbom BE, Yaqoob M, Gustavsson P, Abbas HG, Anneren G, Larsson A, Wadelius C. Linkage analysis identifies the thyroglobulin gene region as a major locus for familial congenital hypothyroidism. Hum Genet 2002;110:145-147.

138 Caron P, Moya CM, Malet D, Gutnisky VJ, Chabardes B, Rivolta CM, Targovnik HM. Compound heterozygous mutations in the thyroglobulin gene (1143delC and 6725 G-->A [R2223H]) resulting in fetal goitrous hypothyroidism. J Clin Endocrinol 2003;88:3546-3553.

139 Van de Graaf SAR, Cammenga C, Ponne NH et al. The screening for mutations in the thyroglobulin cDNA from six patients with congenital hypothyroidism. Biochimie 1999; 81:425-432.

140 Choufour JC, Kassenaar AAH, Querido A. the syndrome of congenital hypothyroidism with defective dehalogenation of iodotyrosines. Further observations and a discussion of the pathophysiology. J Clin Endocrinol Metab 1960;20:983-1003.

141 Stanbury JB, Kassenaar AAH, Meijer JWA, Terpstra J. The occurrence of mono- and di-iodotyrosine in the blood of a patient with congenital goiter. J Clin Endocrinol Metab 1955;15:1216-1227.

142 Ismail-Beigi F, Rahimifar M. A variant of iodotyrosine-dehalogenase deficiency. J Clin Endocrinol Metab 1977; 44: 499-506.

143 Moreno JC,Keijser R, Aaraas S, de Vijlder JJM, Ris-Stalpers C. Cloning and characterization of a novel thyroidal gene encoding proteins with a conserved nitroreductase domain. J Endocrinol Invest 2002;25(suppl):23.

144 Parma J, Duprez L, Van Sande J et al. Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid ademoma. Nature 1993;365:649-651.

145 Duprez L, Parma J, Van Sande et al. Germline mutations in the thyrotropin receptor gene cause non-autosomal dominant hyperthyroidism. Nature Genet 1994;7:396-401.

146 Kopp P, Van Sande J, Parma J et al. Congenital hyperthyroidism caused by a mutation in the thyrotropin-receptor gene. N Engl J Med 1995;332:150-154.

147 Farfel Z, Bourne HR, Liri T. The expanding spectrum of G protein diseases. N Engl J Med 1999;340:1012-1020.